Ipsen

Ipsen is a leading global biopharmaceutical company that specializes in developing and commercializing innovative drugs for the treatment of cancer, rare diseases, and other debilitating conditions. With a strong presence in over 30 countries, Ipsen is dedicated to improving the lives of patients worldwide by providing them with access to cutting-edge therapies that address unmet medical needs. The company's diverse portfolio includes a range of products that target various therapeutic areas, including oncology, neurology, and endocrinology. Ipsen's research and development efforts are focused on discovering new treatments that can make a meaningful difference in the lives of patients. The company is committed to operating with integrity, transparency, and a strong sense of social responsibility, and is dedicated to creating a sustainable future for all stakeholders.